Is Prevest Denpro a good quality company?

Past 10 year's financial track record analysis by Moneyworks4me indicates that Prevest Denpro Ltd is a good quality company .

Is Prevest Denpro undervalued or overvalued?

The key valuation ratios of Prevest Denpro Ltd's currently when compared to its past seem to suggest it is in the Fair zone .

What is Prevest Denpro share price return in the past 10 years?

Data is not available for this company

Is Prevest Denpro a good buy now?

The Price Trend analysis by MoneyWorks4Me indicates it is Weak which suggest that the price of Prevest Denpro Ltd is likely to Fall in the short term. However, please check the rating on Quality and Valuation before investing.

Prevest Denpro Ltd - Stock Valuation and Financial Performance

Name: Prevest Denpro
Brand: Prevest Denpro

BSE: 543363 | NSE: | Medical Equipment/Supplies/Accessories | Small Cap

Place order

Prevest Denpro Share Price

₹430.95 -1.40 -0.32%
as on 26-Apr'24 10:19

10 Year X-Ray of Prevest Denpro:

Analysis of Financial Track Record

Data adjusted to bonus, split, extra-ordinary income, rights issue and change in financial year end

Standalone Basis ^P Consolidated Basis

Data adjusted to bonus, split, extra-ordinary income, rights issue and change in financial year end

Value Creation ⓘ

Value Creation Index Colour Code Guide ⓘ

	Mar'18	Mar'19	Mar'20	Mar'21	Mar'22	Mar'23	TTM
ROCE % ⓘ	26.6%	30.5%	35.8%	35.5%	28.1%	23.7%	-
Value Creation Index ⓘ	0.9	1.2	1.6	1.5	1.0	0.7	-
Growth Parameters ⓘ Growth Parameters Colour Code Guide ⓘ
Sales ⓘ	17	19.3	22.8	28.5	38.1	49.9	54
Sales YoY Gr.	-	13.6%	18.1%	25.1%	33.8%	30.8%	-
Adj EPS ⓘ	2.4	3.3	5.6	8	9.5	12.9	13.8
YoY Gr.	-	39.5%	68.4%	43.1%	18.3%	35.8%	-
BVPS (₹) ⓘ	8.3	11.7	17.3	25.5	47.6	60.7	69.9
Adj Net Profit ⓘ	2.1	2.9	4.9	7.1	11.4	15.4	17
Cash Flow from Ops. ⓘ	2.4	3	4.7	8.8	7	10.7	-
Debt/CF from Ops. ⓘ	0.5	0.5	0.4	0.2	0.2	0	-

CAGR ⓘ

CAGR Colour Code Guide ⓘ

	9 Years	5 Years	3 Years	1 Years
Sales ⓘ	NA	24%	29.9%	30.8%
Adj EPS ⓘ	NA	40.1%	32%	35.8%
BVPSⓘ	NA	49%	51.9%	27.5%
Share Price	-	-	-	29.6%

Key Financial Parameters ⓘ

Performance Ratio Colour Code Guide ⓘ

	Mar'18	Mar'19	Mar'20	Mar'21	Mar'22	Mar'23	TTM
Return on Equity % ⓘ	28.8	33.3	38.6	37.4	28.6	23.8	21.1
Op. Profit Mgn % ⓘ	18	20.1	22.8	31.7	39.9	39.7	36.2
Net Profit Mgn % ⓘ	12.4	15.2	21.7	24.8	29.8	31	30.7
Debt to Equity ⓘ	0.2	0.1	0.1	0.1	0	0	-
Working Cap Days ⓘ	0	69	74	75	76	85	190
Cash Conv. Cycle ⓘ	0	14	19	-4	-2	32	173

Recent Performance Summary

Sales growth is growing at healthy rate in last 3 years 29.85%

Net Profit is growing at healthy rate in last 3 years 31.98%

Sales growth is good in last 4 quarters at 20.25%

Return on Equity has declined versus last 3 years average to 21.10%

Latest Financials - Prevest Denpro Ltd.

	Standalone	Consolidated
TTM EPS (₹)	13.8	-
TTM Sales (₹ Cr.)	54	-
BVPS (₹.) ⓘ	69.9	-
Reserves (₹ Cr.) ⓘ	72	-
P/BV ⓘ	6.18	-
PE ⓘ	31.33	-

From the Market
52 Week Low / High (₹)	326.50 / 607.50
All Time Low / High (₹)	170.65 / 607.50
Market Cap (₹ Cr.)	519
Equity (₹ Cr.)	12
Face Value (₹)	10
Industry PE ⓘ	58.8

Management X-Ray of Prevest Denpro:

Shareholding Pattern

Promoter's Holding & Share Pledging

Pledged ^*

0.00

* Pledged shares as % of Promoter's holding (%)

Valuation of Prevest Denpro

Price Calculator

Price Chart

Price to Earnings

Enterprise Value to EBIT

Price to Book-Value

Price to Sales

Dividend History

Analyst's Notes

This is a premium feature, Please click here to check our solutions.

Key Ratios of Prevest Denpro

Standalone Basis Consolidated Basis

Adj EPS (Rs.)

Sales (Cr.)

ROE (%)

ROCE (%)

Profit And Loss

(All Figures are in Crores.)

Standalone Basis Consolidated Basis

PARTICULARS	Mar'18	Mar'19	Mar'20	Mar'21	Mar'22	Mar'23
Sales	17	19	23	28	38	50
Operating Expenses ⓘ	14	15	18	19	23	30
Manufacturing Costs	1	1	1	0	0	0
Material Costs	5	6	7	8	10	12
Employee Cost	3	3	5	3	4	5
Other Costs ⓘ	5	5	5	8	9	12
Operating Profit ⓘ	3	4	5	9	15	20
Operating Profit Margin (%)	17.4%	20.1%	22.8%	31.7%	39.9%	39.7%
Other Income ⓘ	1	0	2	1	2	2
Interest ⓘ	0	0	0	0	0	0
Depreciation ⓘ	0	0	0	0	1	1
Exceptional Items ⓘ	0	0	0	0	0	0
Profit Before Tax ⓘ	3	4	6	9	16	21
Tax ⓘ	1	1	1	2	4	5
Profit After Tax	2	3	5	7	12	16
PAT Margin (%)	12.8%	15.5%	22.0%	25.3%	30.4%	31.5%
Adjusted EPS (₹)	2.5	3.4	5.7	8.2	9.6	13.1
Dividend Payout Ratio (%)	0%	0%	0%	0%	0%	8%

Balance Sheet

(All Figures are in Crores.)

Standalone Basis Consolidated Basis

PARTICULARS	Mar'18	Mar'19	Mar'20	Mar'21	Mar'22	Mar'23
Equity and Liabilities
Shareholders Fund	7	10	15	22	57	73
Share Capital ⓘ	0	0	0	0	12	12
Reserves ⓘ	7	10	15	22	45	61
Minority Interest	0	0	0	0	0	0
Debt	1	1	2	1	1	0
Long Term Debt	1	1	2	1	1	0
Short Term Debt	0	0	0	0	0	0
Trade Payables	1	1	1	4	2	1
Others Liabilities ⓘ	2	2	3	3	4	4
Total Liabilities ⓘ	11	15	21	31	64	79
Fixed Assets
Gross Block	6	8	8	9	11	12
Accumulated Depreciation	2	3	3	4	4	5
Net Fixed Assetsⓘ	4	5	5	5	7	7
CWIP ⓘ	0	0	0	2	5	17
Investmentsⓘ	0	0	0	0	1	1
Inventories	0	0	1	1	3	5
Trade Receivables	2	2	2	4	2	4
Cash Equivalents ⓘ	4	6	10	16	42	39
Others Assetsⓘ	1	1	2	2	4	5
Total Assets ⓘ	11	15	21	31	64	79

Cash Flow

(All Figures are in Crores.)

Standalone Basis Consolidated Basis

PARTICULARS	Mar'18	Mar'19	Mar'20	Mar'21	Mar'22	Mar'23
Cash Flow From Operating Activity ⓘ	2	3	5	9	7	11
PBT ⓘ	3	4	6	9	16	21
Adjustment ⓘ	1	0	0	0	-1	-1
Changes in Working Capital ⓘ	-1	-0	-1	1	-4	-4
Tax Paid ⓘ	-1	-1	-1	-2	-4	-5
Cash Flow From Investing Activity ⓘ	-1	-1	-1	-2	-4	-12
Capex	-1	-1	-1	-2	-5	-14
Net Investments	0	0	0	0	0	0
Others ⓘ	0	0	0	1	1	2
Cash Flow From Financing Activityⓘ	0	0	0	-1	23	-2
Net Proceeds from Shares ⓘ	0	0	0	0	23	0
Net Proceeds from Borrowing ⓘ	0	0	0	0	0	-1
Interest Paid ⓘ	0	0	0	0	0	0
Dividend Paid ⓘ	0	0	0	0	0	0
Others ⓘ	0	0	0	0	0	0
Net Cash Flow ⓘ	1	2	4	6	26	-3

Finance Ratio

Standalone Basis Consolidated Basis

PARTICULARS	Mar'18	Mar'19	Mar'20	Mar'21	Mar'22	Mar'23
Ratios
ROE (%)	29.72	34.02	39.13	38.13	29.07	24.19
ROCE (%)	37.15	39.27	45.63	46.96	39.64	32.25
Asset Turnover Ratio	1.54	1.49	1.28	1.12	0.83	0.71
PAT to CFO Conversion(x)	1	1	1	1.29	0.58	0.69
Working Capital Days
Receivable Days	32	37	36	37	28	24
Inventory Days	10	9	13	15	21	29
Payable Days	72	64	69	122	105	44

Prevest Denpro Ltd Stock News

Prevest Denpro Ltd FAQs

What is the share price of Prevest Denpro?

Company share prices are keep on changing according to the market conditions. The closing price of Prevest Denpro on 26-Apr-2024 10:19 is ₹430.9.

What is the market cap of Prevest Denpro?

Market capitalization or market cap is determined by multiplying the current market price of a company's shares with the total number of shares outstanding. As of 26-Apr-2024 10:19 the market cap of Prevest Denpro stood at ₹519.0.

What is the P/E ratio of Prevest Denpro?

The latest P/E ratio of Prevest Denpro as of 26-Apr-2024 10:19 is 31.33.

What is the P/B ratio of Prevest Denpro?

The latest P/B ratio of Prevest Denpro as of 26-Apr-2024 10:19 is 6.18.

What is the 52-week high and low of Prevest Denpro?

The 52-week high of Prevest Denpro is ₹607.5 and the 52-week low is ₹326.5.

What is the TTM revenue of Prevest Denpro?

The TTM revenue is Trailing Twelve Months sales. The TTM revenue/sales of Prevest Denpro is ₹53.97 ( Cr.) .

About Prevest Denpro Ltd

The company develops, manufacture and market a comprehensive portfolio of dental materials for diagnosing, treating and preventing dental conditions as well as improving the aesthetics of the human smile. The breadth and depth of its product offerings address majority of the dentists’ clinical needs for consumable dental materials. Its product portfolio covers a wide spectrum of materials for endodontics, prosthodontics, orthodontics, periodontics, restorative dentistry, aesthetic dentistry and laboratory consumables. Its products are sold in the regions of Europe, Asia, South America, Middle East and Africa. Further, as per its diversification plans, the company is currently expanding its existing manufacturing unit by setting up another manufacturing facility for manufacturing new line of products that will include hygiene products (sanitizers and disinfectants), oral hygiene products (mouth washes and mouth rinses), oral care products(medicated ointments, gels and creams for dental treatment) and biomaterials (i.e. bone augmentation materials). The proposed facility will be well-equipped with latest machineries.

Business area of the company

The company manufactures and markets a range of dental materials for diagnosing, treating, and preventing dental conditions and improving the aesthetics of the human smile.

Key events and milestones

1999: Incorporation of the Company.
2000: First Manufacturing unit was established at Digiana, Jammu, J&K.
2011: Second Manufacturing unit was established at Samba, J&K.
2014-15: Crossed Turnover of Rs 10 crore.
2016: Won Sushruta award for Best Dental Manufacture by the Indian Dental Association’s.
2016: Received Certificate for ‘Best Enterprise’ in the field of manufacture of dental materials, India by the Socrates Committee, Oxford, UK.
2017: Shifted manufacturing operations from First Manufacturing Unit to Second Manufacturing unit.
2017: Won “Northern Region Export Excellence Award” - Gold Trophy for outstanding export performance in the category of top exporter J&K - SME by FIEO (2017).
2019-20: Crossed Turnover of Rs 20 crore.